Researchers have demonstrated that GNG12 could regulate cancer cell proliferation, inflammatory response, and immune response via activating the mTORC1 pathway and NF-κB signaling pathway (Larson et al., 2010; Luo et al., 2018; Li et al., 2020). Here, NFKB1 is linked to cancer.